NCT04510311 2025-01-10
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
Clinical Trials
11 trialsNCT01873248 2024-07-19
Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT05871320 2023-09-29
TECANT
Jagiellonian University
Phase EARLY_PHASE1 Completed
NCT05361083 2022-05-04
First-in-human Evaluation of [18F]CETO
Uppsala University
Phase EARLY_PHASE1 Completed
NCT04804163 2022-02-16
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
The Affiliated Hospital of Qingdao University
Phase EARLY_PHASE1 Completed
NCT03647657 2022-02-10
177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Completed
NCT03197012 2020-07-07
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT04440956 2020-06-22
An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours
Clarity Pharmaceuticals Ltd
Phase EARLY_PHASE1 Completed
NCT01459237 2018-06-14
Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02493959 2015-07-10
Degradation of the Anorexic Hormone Peptide YY
Hvidovre University Hospital
Phase EARLY_PHASE1 Completed
NCT00436410 2012-05-02
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed